TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells - PubMed (original) (raw)
Comparative Study
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
Julien C Marie et al. J Exp Med. 2005.
Abstract
Transforming growth factor (TGF)-beta1 is a major pluripotential cytokine with a pronounced immunosuppressive effect and its deficiency results in lethal autoimmunity in mice. However, mechanisms of its immunosuppressive action are not completely understood. Here, we report that TGF-beta1 supports the maintenance of Foxp3 expression, regulatory function, and homeostasis in peripheral CD4(+)CD25(+) regulatory T (T reg) cells, but is not required for their thymic development. We found that in 8-10-d-old TGF-beta1-deficient mice, peripheral, but not thymic, T reg cells are significantly reduced in numbers. Moreover, our experiments suggest that a defect in TGF-beta-mediated signaling in T reg cells is associated with a decrease in Foxp3 expression and suppressor activity. Thus, our results establish an essential link between TGF-beta1 signaling in peripheral T reg cells and T reg cell maintenance in vivo.
Figures
Figure 1.
Decrease in peripheral CD4+CD25+ T cells in _Tgf-β_1 −/− mice. Thymocytes (a) and splenocytes (b and c) from 8–10-d-old _Tgf-β_1 − / − mice or littermate controls were counted and stained for CD4 and CD8 and analyzed by flow cytometry. Peripheral CD4 T cells from _Tgf-β_1 −/− mice (gray line) or littermate controls (black line) were stained for CD44 and CD62L. Thymocytes and splenocytes from 8–10-d-old _Tgf-β_1 − / − mice or littermate controls were stained for CD4 and CD25 and analyzed by flow cytometry (d). Proportion of CD4+CD25+ cells among CD4 T cells (e, n = 20).
Figure 2.
Decrease in Foxp3 level in _Tgf-β_1 −/− CD4+CD25+ T cells. Thymocytes and splenocytes from 8–10-d-old _Tgf-β_1 − / − mice or littermate controls were stained for CD4 and CD25 followed by anti-Foxp3 intracellular staining and analyzed by flow cytometry. Foxp3 staining in CD4+CD25− T cells (black line) and in CD4+CD25+ (gray line) are shown. Isotype control staining is shown (dashed line). These results are representative of three different experiments.
Figure 3.
TGF-β1 is required to maintain Foxp3 in CD4+CD25+ T cells. T reg cells purified from spleen of 8–10-d-old _Tgf-β_1 − / − mice or littermate controls were transferred into TCRβ/δ-deficient mice injected every other day with anti–TGF-β1 antibody or isotype control IgG. 4 d after transfer, cells from spleen and lymph nodes were stained for CD4 and CD25 followed by anti-Foxp3 intracellular staining and analyzed by flow cytometry (a). Results are representative of three different experiments. Serum TGF-β1 in treated animals was measured by ELISA (b). Western blot analysis of Smad2 phosphorylation and Foxp3 expression in purified wild-type T reg cells either freshly isolated or cultured for 24 h in the presence or absence of 100 pg/ml TGF-β1 (c).
Figure 4.
TGF-β signaling is required to maintain regulatory function T reg cells. (a) Analysis of suppressor activity of T reg cells isolated from _Tgf-β_1 − / − (gray symbols) or WT littermates (Lit, black symbols) in cocultures with freshly isolated B6 CD4+CD25− responder T cells in the presence of either _Tgf-β_1 − / − or littermate control APCs and Con A. Proliferation of CD4+CD25− T cells was determined after 72 h of culture by [3H]thymidine incorporation. Proliferation of CD4+CD25+ from either control or _Tgf-β_1 − / − mice in response to Con A was ∼300–500 cpm. The results are shown as mean cpm of [3H]thymidine incorporation in triplicate cultures ± SD. (b) T reg cells transduced with DN–TGF-βRII–MigR2 (MigR2 DN) or empty vector control (MigR2 Ev) were purified and cocultured with freshly isolated B6 CD4+CD25− responder T cells in the presence of irradiated T cell–depleted splenic APCs and Con A. Proliferation was measured as described before. Results are representative of two or three different experiments.
Similar articles
- T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.
Fahlén L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F. Fahlén L, et al. J Exp Med. 2005 Mar 7;201(5):737-46. doi: 10.1084/jem.20040685. J Exp Med. 2005. PMID: 15753207 Free PMC article. - TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M, Piccirillo CA. Pyzik M, et al. J Leukoc Biol. 2007 Aug;82(2):335-46. doi: 10.1189/jlb.1006644. Epub 2007 May 2. J Leukoc Biol. 2007. PMID: 17475784 - Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.
Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Fantini MC, et al. J Immunol. 2004 May 1;172(9):5149-53. doi: 10.4049/jimmunol.172.9.5149. J Immunol. 2004. PMID: 15100250 - Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
Zhang L, Yi H, Xia XP, Zhao Y. Zhang L, et al. Autoimmunity. 2006 Jun;39(4):269-76. doi: 10.1080/08916930600753903. Autoimmunity. 2006. PMID: 16891215 Review. - TGF-beta and CD4+CD25+ regulatory T cells.
Huber S, Schramm C. Huber S, et al. Front Biosci. 2006 Jan 1;11:1014-23. doi: 10.2741/1859. Front Biosci. 2006. PMID: 16146793 Review.
Cited by
- Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside.
Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, Xu X, Nie Y, Fan D, Wu K, Xia L. Yin Y, et al. Exp Hematol Oncol. 2024 Aug 1;13(1):72. doi: 10.1186/s40164-024-00539-x. Exp Hematol Oncol. 2024. PMID: 39085965 Free PMC article. Review. - Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment.
Mashayekhi K, Khazaie K, Faubion WA Jr, Kim GB. Mashayekhi K, et al. Bioact Mater. 2024 Apr 22;37:269-298. doi: 10.1016/j.bioactmat.2024.03.030. eCollection 2024 Jul. Bioact Mater. 2024. PMID: 38694761 Free PMC article. Review. - Targeting tumor-infiltrating tregs for improved antitumor responses.
Qin D, Zhang Y, Shu P, Lei Y, Li X, Wang Y. Qin D, et al. Front Immunol. 2024 Mar 4;15:1325946. doi: 10.3389/fimmu.2024.1325946. eCollection 2024. Front Immunol. 2024. PMID: 38500876 Free PMC article. Review. - Regulatory T Cells for Control of Autoimmunity.
Kawakami R, Sakaguchi S. Kawakami R, et al. Adv Exp Med Biol. 2024;1444:67-82. doi: 10.1007/978-981-99-9781-7_5. Adv Exp Med Biol. 2024. PMID: 38467973 - Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy.
Stanilov N, Velikova T, Stanilova S. Stanilov N, et al. Int J Mol Sci. 2024 Jan 13;25(2):1009. doi: 10.3390/ijms25021009. Int J Mol Sci. 2024. PMID: 38256080 Free PMC article. Review.
References
- Sakaguchi, S., N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda, and T. Takahashi. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18–32. - PubMed
- Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389–400. - PubMed
- Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431–440. - PubMed
- Stephens, L.A., and D. Mason. 2000. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25− subpopulations. J. Immunol. 165:3105–3110. - PubMed
- Annacker, O., R. Pimenta-Araujo, O. Burlen-Defranoux, and A. Bandeira. 2001. On the ontogeny and physiology of regulatory T cells. Immunol. Rev. 182:5–17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI061816/AI/NIAID NIH HHS/United States
- R37 AI034206/AI/NIAID NIH HHS/United States
- R01 AI034206/AI/NIAID NIH HHS/United States
- AI061816/AI/NIAID NIH HHS/United States
- AI34206/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials